PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 7276568-3 1981 C-reactive protein previously was shown to selectively and reversibly precipitate with certain small polymers of arginine and lysine. Arginine 113-121 C-reactive protein Homo sapiens 0-18 1460031-10 1992 We conclude that the residues Lys-57, Arg-58, and Trp-67 contribute to the structure of the PCh-binding site of human CRP. Arginine 38-41 C-reactive protein Homo sapiens 118-121 2692716-8 1989 Protease-cleaved CRP loses the ability to bind to the Ca2+-dependent ligand phosphorylcholine but remains the ability to bind to the Ca2+-independent ligand arginine-rich histone. Arginine 157-165 C-reactive protein Homo sapiens 17-20 6877243-2 1983 CRP binds with phosphocholine and phosphate esters; initiates reactions of agglutination, opsonization and complement consumption; and precipitates with protamine and synthetic polymers of lysine and arginine, and these reactivities are modulated by calcium and phosphocholine. Arginine 200-208 C-reactive protein Homo sapiens 0-3 25734013-11 2015 Arginine treated patients had significantly increased BMI at the end of the first and second months of treatment (P = 0.032 and P = 0.04) and a reduced CRP at the end of the first month of treatment (P = 0.03) versus placebo group. Arginine 0-8 C-reactive protein Homo sapiens 152-155 31780028-0 2019 Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials. Arginine 10-20 C-reactive protein Homo sapiens 40-58 31780028-1 2019 OBJECTIVES: We carried out a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effect of L-arginine on inflammatory biomarkers including C-reactive protein (CRP), interleukin-6 (IL-6) and TNFalpha. Arginine 128-138 C-reactive protein Homo sapiens 176-194 31780028-7 2019 However, when subgroup analysis was performed, we found that L-arginine supplementation increased CRP levels in subjects with ages >60 years old, participants with baseline circulating CRP levels >3 mg/dl, patients with cancer and when used in enteral formula. Arginine 61-71 C-reactive protein Homo sapiens 98-101 31780028-7 2019 However, when subgroup analysis was performed, we found that L-arginine supplementation increased CRP levels in subjects with ages >60 years old, participants with baseline circulating CRP levels >3 mg/dl, patients with cancer and when used in enteral formula. Arginine 61-71 C-reactive protein Homo sapiens 185-188 31780028-8 2019 CONCLUSION: Results of the present meta-analysis indicated that L-arginine supplementation increased the circulating concentrations of CRP in subjects with ages >60 years old, subjects with higher levels of CRP, patients with cancer and when used in enteral formula. Arginine 64-74 C-reactive protein Homo sapiens 135-138 31780028-8 2019 CONCLUSION: Results of the present meta-analysis indicated that L-arginine supplementation increased the circulating concentrations of CRP in subjects with ages >60 years old, subjects with higher levels of CRP, patients with cancer and when used in enteral formula. Arginine 64-74 C-reactive protein Homo sapiens 207-210 31699008-2 2021 Recently, scientists studied L-arginine effect on inflammatory mediators such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). Arginine 29-39 C-reactive protein Homo sapiens 81-99 31699008-2 2021 Recently, scientists studied L-arginine effect on inflammatory mediators such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). Arginine 29-39 C-reactive protein Homo sapiens 101-104 28851320-7 2017 In the multiple regression analysis performed in cilostazol group, serum L-arginine levels were inversely correlated with FMD at T1 (ss = -0.050, SE: 0.012, p < 0.001) with age, total cholesterol levels, and C-reactive protein as confounders. Arginine 73-83 C-reactive protein Homo sapiens 211-229 19232413-6 2009 All patients were genotyped for a frequent functional variant at position 131 of the mature FcgammaRIIa, where the arginine (R) allele results in an increased signal transduction upon CRP binding. Arginine 115-123 C-reactive protein Homo sapiens 184-187 23918883-8 2013 The initial results showed an activation of both l-arginine influx and via system y (+ )L associated with reduced intraplatelet cGMP levels in periodontitis patients and increased systemic levels of CRP. Arginine 49-59 C-reactive protein Homo sapiens 199-202 21306304-4 2011 The arginine/ADMA ratio decreased significantly across increasing tertiles of CRP and MPO. Arginine 4-12 C-reactive protein Homo sapiens 78-81 21306304-8 2011 Conversely, in a fully adjusted model, CRP was negatively associated with arginine [-2.8 (95% CI, -4.0 to -1.6) mumol/l arginine per S.D. Arginine 74-82 C-reactive protein Homo sapiens 39-42 21306304-8 2011 Conversely, in a fully adjusted model, CRP was negatively associated with arginine [-2.8 (95% CI, -4.0 to -1.6) mumol/l arginine per S.D. Arginine 120-128 C-reactive protein Homo sapiens 39-42 21306304-12 2011 In contrast, the relationship between CRP and arginine was not modified by levels of oxLDL. Arginine 46-54 C-reactive protein Homo sapiens 38-41 21406573-6 2011 Patients with high plasma concentrations of C-reactive protein and mice with acute inflammation induced by lipopolysaccharide had significant reductions of arginine metabolites in plasma compared with controls. Arginine 156-164 C-reactive protein Homo sapiens 44-62 19965803-5 2010 The presence of an arginine instead of a histidine residue at amino acid position 131 (H131R) in the extracellular domain of FcgammaRIIa reduces the affinity of the receptor for IgG(2) and IgG(3) isotypes but increases the binding activity for C reactive protein (CRP). Arginine 19-27 C-reactive protein Homo sapiens 244-262 19965803-5 2010 The presence of an arginine instead of a histidine residue at amino acid position 131 (H131R) in the extracellular domain of FcgammaRIIa reduces the affinity of the receptor for IgG(2) and IgG(3) isotypes but increases the binding activity for C reactive protein (CRP). Arginine 19-27 C-reactive protein Homo sapiens 264-267 19174069-2 2009 The aim of our study was to evaluate the effect of enteral nutrition supplemented with a high dose of arginine on c-reactive protein (CRP), interleukin 6 (IL6) and tumoral necrosis factor (TNF alpha) in surgical head and neck cancer patients. Arginine 102-110 C-reactive protein Homo sapiens 114-132 12548303-0 2003 Effect of c-reactive protein and interleukins blood levels in postsurgery arginine-enhanced enteral nutrition in head and neck cancer patients. Arginine 74-82 C-reactive protein Homo sapiens 10-28 12548303-3 2003 The aim of our study was to evaluate the effect of enteral nutrition supplemented with arginine on c-reactive protein (CRP), interleukin 6 (IL-6) and tumour necrosis factor (TNFalpha) in surgical head and neck cancer patients. Arginine 87-95 C-reactive protein Homo sapiens 99-117 10675363-4 2000 Because the single nucleotide polymorphism in FcgammaRIIA - which encodes histidine or arginine at position 131 - strongly influences IgG2 binding, we determined this polymorphism"s effect on CRP binding. Arginine 87-95 C-reactive protein Homo sapiens 192-195